H. Burstein and J. Griggs, Adjuvant Hormonal Therapy for Early-Stage Breast Cancer, Surgical Oncology Clinics of North America, vol.19, issue.3, pp.639-647, 2010.
DOI : 10.1016/j.soc.2010.03.006

W. Janni and P. Hepp, Adjuvant aromatase inhibitor therapy: Outcomes and safety, Cancer Treatment Reviews, vol.36, issue.3, pp.249-261
DOI : 10.1016/j.ctrv.2009.12.010

R. Michalides, A. Griekspoor, A. Balkenende, D. Verwoerd, L. Janssen et al., Tamoxifen resistance by a conformational arrest of the estrogen receptor ?? after PKA activation in breast cancer, Cancer Cell, vol.5, issue.6, pp.597-605, 2004.
DOI : 10.1016/j.ccr.2004.05.016

D. Cosimo, S. Baselga, and J. , Targeted therapies in breast cancer: Where are we now?, European Journal of Cancer, vol.44, issue.18, pp.2781-2790, 2008.
DOI : 10.1016/j.ejca.2008.09.026

S. Massarweh, C. Osborne, C. Creighton, L. Qin, A. Tsimelzon et al., Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function, Cancer Research, vol.68, issue.3, pp.68826-833, 2008.
DOI : 10.1158/0008-5472.CAN-07-2707

R. Saxena and A. Dwivedi, ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective, Medicinal Research Reviews, vol.16, issue.1, pp.166-215
DOI : 10.1002/med.20209

O. Prall, E. Rogan, E. Musgrove, C. Watts, and R. Sutherland, c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry, Molecular and Cellular Biology, vol.18, issue.8, pp.184499-4508, 1998.
DOI : 10.1128/MCB.18.8.4499

G. Castoria, A. Migliaccio, A. Bilancio, D. Domenico, M. De-falco et al., Auricchio F: PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells, EMBO J, issue.21, pp.206050-6059, 2001.

A. Gaben, C. Saucier, M. Bedin, G. Redeuilh, and J. Mester, Mitogenic Activity of Estrogens in Human Breast Cancer Cells Does Not Rely on Direct Induction of Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase or Phosphatidylinositol 3-Kinase, Molecular Endocrinology, vol.18, issue.11, pp.182700-2713, 2004.
DOI : 10.1210/me.2003-0133

B. Dufourny, J. Alblas, H. Van-teeffelen, F. Van-schaik, B. Van-der-burg et al., Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase, Journal of Biological Chemistry, vol.272, issue.49, pp.27231163-31171, 1997.
DOI : 10.1074/jbc.272.49.31163

A. Lai, B. Sarcevic, O. Prall, and R. Sutherland, Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1), J Biol Chem, issue.28, pp.27625823-25833, 2001.

H. Varma and S. Conrad, Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling, Cancer Res, issue.14, pp.623985-3991, 2002.

B. Wittmann, A. Sherk, and D. Mcdonnell, Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators, Cancer Research, vol.67, issue.19, pp.9549-9560, 2007.
DOI : 10.1158/0008-5472.CAN-07-1590

F. Czauderna, M. Fechtner, H. Aygun, W. Arnold, A. Klippel et al., Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA, Nucleic Acids Research, vol.31, issue.2, pp.31670-682, 2003.
DOI : 10.1093/nar/gkg141

G. Xiao, M. Jeffers, A. Bellacosa, Y. Mitsuuchi, V. Woude et al., Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways, Proceedings of the National Academy of Sciences, vol.98, issue.1, pp.247-252, 2001.
DOI : 10.1073/pnas.98.1.247

I. Remy, A. Montmarquette, and S. Michnick, PKB/Akt modulates TGF-?? signalling through a direct interaction with Smad3, Nature Cell Biology, vol.6, issue.4, pp.358-365, 2004.
DOI : 10.1038/ncb1113

B. Henglein, X. Chenivesse, J. Wang, D. Eick, and C. Brechot, Structure and cell cycle-regulated transcription of the human cyclin A gene., Proceedings of the National Academy of Sciences, vol.91, issue.12, pp.915490-5494, 1994.
DOI : 10.1073/pnas.91.12.5490

A. Fritah, C. Saucier, J. Mester, and G. Redeuilh, p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor ??, Molecular and Cellular Biology, vol.25, issue.6, pp.2419-2430, 2005.
DOI : 10.1128/MCB.25.6.2419-2430.2005

A. Conery, Y. Cao, E. Thompson, C. Townsend, . Jr et al., Akt interacts directly with Smad3 to regulate the sensitivity to TGF-??-induced apoptosis, Nature Cell Biology, vol.6, issue.4, pp.366-372, 2004.
DOI : 10.1038/ncb1117

K. Nakatani, D. Thompson, A. Barthel, H. Sakaue, W. Liu et al., Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines, Journal of Biological Chemistry, vol.274, issue.31, pp.27421528-21532, 1999.
DOI : 10.1074/jbc.274.31.21528

M. Zinda, M. Johnson, J. Paul, C. Horn, B. Konicek et al., AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon, Clin Cancer Res, vol.7, issue.8, pp.2475-2479, 2001.

J. Carroll, D. Lynch, A. Swarbrick, J. Renoir, B. Sarcevic et al., (Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells, Cancer Res, issue.15, pp.27-634322, 2003.

M. Polo, M. Arnoni, M. Riggio, V. Wargon, C. Lanari et al., Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice, PLoS ONE, vol.70, issue.5, p.10786, 2010.
DOI : 10.1371/journal.pone.0010786.g008

S. Wardell, J. Marks, and D. Mcdonnell, The turnover of estrogen receptor ?? by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy, Biochemical Pharmacology, vol.82, issue.2, pp.122-130, 2011.
DOI : 10.1016/j.bcp.2011.03.031

I. Rosenwald, N. Setkov, V. Kazakov, J. Chen, A. Ryazanov et al., Transient inhibition of protein synthesis induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle, Cell Proliferation, vol.25, issue.12, pp.28631-644, 1995.
DOI : 10.1038/340064a0

F. Vinals, J. Chambard, and J. Pouyssegur, p70 S6 Kinase-mediated Protein Synthesis Is a Critical Step for Vascular Endothelial Cell Proliferation, Journal of Biological Chemistry, vol.274, issue.38, pp.7026776-26782, 1999.
DOI : 10.1074/jbc.274.38.26776

J. Diehl, M. Cheng, M. Roussel, and C. Sherr, Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization, Genes & Development, vol.12, issue.22, pp.3499-3511, 1998.
DOI : 10.1101/gad.12.22.3499

D. Gagne, P. Balaguer, E. Demirpence, C. Chabret, F. Trousse et al., Stable luciferase transfected cells for studying steroid receptor biological activity, Journal of Bioluminescence and Chemiluminescence, vol.5, issue.3, pp.201-209, 1994.
DOI : 10.1002/bio.1170090314

A. Fowler, N. Solodin, C. Valley, and E. Alarid, Altered Target Gene Regulation Controlled by Estrogen Receptor-?? Concentration, Molecular Endocrinology, vol.20, issue.2, pp.291-301, 2006.
DOI : 10.1210/me.2005-0288

M. Sabbah, D. Courilleau, J. Mester, and G. Redeuilh, Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element, Proceedings of the National Academy of Sciences, vol.96, issue.20, pp.11217-11222, 1999.
DOI : 10.1073/pnas.96.20.11217

E. Klein and R. Assoian, Transcriptional regulation of the cyclin D1 gene at a glance, Journal of Cell Science, vol.121, issue.23, pp.3853-3857, 2008.
DOI : 10.1242/jcs.039131

J. Dupont, M. Karas, and D. Leroith, The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells, Journal of Biological Chemistry, vol.278, issue.39, pp.27837256-37264, 2003.
DOI : 10.1074/jbc.M302355200

M. Becker, Y. Ibrahim, X. Cui, A. Lee, and Y. D. , The IGF Pathway Regulates ER?? through a S6K1-Dependent Mechanism in Breast Cancer Cells, Molecular Endocrinology, vol.25, issue.3, pp.516-528, 2011.
DOI : 10.1210/me.2010-0373

C. Morelli, M. Lanzino, C. Garofalo, P. Maris, E. Brunelli et al., Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor ?? Transcriptional Activity in Breast Cancer Cells, Molecular and Cellular Biology, vol.30, issue.3, pp.857-870, 2010.
DOI : 10.1128/MCB.00824-09

Y. Zhang, M. Moerkens, S. Ramaiahgari, H. De-bont, L. Price et al., Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes, Breast Cancer Research, vol.19, issue.Suppl 1, p.52, 2011.
DOI : 10.1093/bioinformatics/btg345

A. Mawson, A. Lai, J. Carroll, C. Sergio, C. Mitchell et al., Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1, Molecular and Cellular Endocrinology, vol.229, issue.1-2, pp.161-173, 2005.
DOI : 10.1016/j.mce.2004.08.002

A. Lee, C. Weng, J. Jackson, and Y. D. , Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells, Journal of Endocrinology, vol.152, issue.1, pp.39-47, 1997.
DOI : 10.1677/joe.0.1520039

A. Charpentier, A. Bednarek, R. Daniel, K. Hawkins, K. Laflin et al., Aldaz CM: Effects of estrogen on global gene expression: identification of novel targets of estrogen action, Cancer Res, issue.21, pp.605977-5983, 2000.

J. Frasor, J. Danes, B. Komm, K. Chang, C. Lyttle et al., Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype, Endocrinology, vol.144, issue.10, pp.1444562-4574, 2003.
DOI : 10.1210/en.2003-0567

S. Reagan-shaw and N. Ahmad, RNA Interference-Mediated Depletion of Phosphoinositide 3-Kinase Activates Forkhead Box Class O Transcription Factors and Induces Cell Cycle Arrest and Apoptosis in Breast Carcinoma Cells, Cancer Research, vol.66, issue.2, pp.1062-1069, 2006.
DOI : 10.1158/0008-5472.CAN-05-1018

B. Burgering, A brief introduction to FOXOlogy, Oncogene, vol.14, issue.16, pp.2258-2262, 2008.
DOI : 10.1074/jbc.M106091200

Y. Zou, W. Tsai, C. Cheng, C. Hsu, Y. Chung et al., Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis, Breast Cancer Research, vol.10, issue.1, p.21, 2008.
DOI : 10.1186/bcr1872

K. Vanderlaag, S. Hudak, L. Bald, L. Fayadat-dilman, M. Sathe et al., Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin, Breast Cancer Res BCR, vol.2010, issue.123, p.32

S. Johnston, New Strategies in Estrogen Receptor-Positive Breast Cancer, Clinical Cancer Research, vol.16, issue.7, pp.1979-1987
DOI : 10.1158/1078-0432.CCR-09-1823

A. Klinakis, M. Szabolcs, G. Chen, S. Xuan, H. Hibshoosh et al., Igf1r as a therapeutic target in a mouse model of basal-like breast cancer, Proceedings of the National Academy of Sciences, vol.106, issue.7, pp.2359-2364, 2009.
DOI : 10.1073/pnas.0810221106

. Gaben, Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells, BMC Cancer, vol.106, issue.7, p.291, 2012.
DOI : 10.1073/pnas.0810221106
URL : https://hal.archives-ouvertes.fr/inserm-00743408